4/A
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-034501
Director acquired 43,104 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vallone Carol A Director | 2022-06-01 | Grant or award | +43,104 | 43,104 | D | ||
| Derivatives | |||||||
| Vallone Carol A Director | 2022-06-01 | Grant or award · Stock Option (Right to Buy) | +133,744 | 161,587 | D | ||
| Vallone Carol A Director | 2022-06-01 | Grant or award · Director's Deferred Share Units | +98,198 | 126,041 | D | ||
| Vallone Carol A Director | 2022-06-01 | Grant or award · Director's Deferred Share Units | +774,673 | 802,516 | D | ||
| Vallone Carol A Director | 2022-06-01 | Grant or award · Director's Deferred Share Units | +34,353 | 62,196 | D | ||
Loading xslF345X03/doc4a.xml…